Art

J-GLOBAL ID：201802246598049143   Reference number：18A0731143

Add-on iguratimod as a therapeutic strategy to achieve remission in patients with rheumatoid arthritis inadequately responding to biological DMARDs: A retrospective study

生物学的DMARDに不十分に応答する関節リウマチ患者において寛解を達成するための治療戦略としてのアドオンイグラチモド:遡及的研究

Author (9)： YOSHIKAWA Ayaka (Osaka Medical Coll., Osaka, JPN) ,  YOSHIDA Shuzo (Osaka Medical Coll., Osaka, JPN) ,  KIMURA Yuko (Osaka Medical Coll., Osaka, JPN) ,  TOKAI Nao (Osaka Medical Coll., Osaka, JPN) ,  FUJIKI Yohei (Osaka Medical Coll., Osaka, JPN) ,  KOTANI Takuya (Osaka Medical Coll., Osaka, JPN) ,  MATSUMURA Yoko (Osaka Medical Coll., Osaka, JPN) ,  TAKEUCHI Tohru (Osaka Medical Coll., Osaka, JPN) ,  MAKINO Shigeki (Osaka Medical Coll., Osaka, JPN)
Material： Modern Rheumatology  (Mod Rheumatol)
Volume： 28  Issue： 2  Page： 227-234  Publication year： Mar. 2018 
JST Material Number： L5142A  ISSN： 1439-7595  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *disease modifying antirheumatic drug ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A0731143&from=J-GLOBAL&jstjournalNo=L5142A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for musculoskeletal diseases  (GG05020D)

Substance index (1)： T-614

Reference (42)：

• Wolfe F, Hawley DJ. The longterm outcomes of rheumatoid arthritis: work disability: a prospective 18 year study of 823 patients. J Rheumatol. 1998;25:2108-17.
• van der Heijde D, Burmester G, Melo-Gomes J, Codreanu C, Mola EM, Pedersen R, et al. The safety and efficacy of adding etanercept to methotrexate or methotrexate to etanercept in moderately active rheumatoid arthritis patients previously treated with monotherapy. Ann Rheum Dis. 2008;67:182-8.
• Takeuchi T, Miyasaka N, Inoue K, Abe T, Koike T. Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study. Mod Rheumatol. 2009;19:478-87.
• Tanaka Y, Harigai M, Takeuchi T, Yamanaka H, Ishiguro N, Yamamoto K, et al. Golimumab in combination with methotrexate in Japanese patients with active rheumatoid arthritis: results of the GO-FORTH study. Ann Rheum Dis. 2012;71:817-24.
• Yamamoto K, Takeuchi T, Yamanaka H, Ishiguro N, Tanaka Y, Eguchi K, et al. Efficacy and safety of certolizumab pegol plus methotrexate in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: the J-RAPID randomized, placebo-controlled trial. Mod Rheumatol. 2014;24:715-24.

Terms in the title (7)： 生物学的DMARD ,  応答 ,  関節リウマチ ,  患者 ,  寛解 ,  治療戦略 ,  遡及的研究